Related Blog Posts
Einstein Receives High-Risk/High-Reward Cancer Research Funding
14 hours ago ago from ZAMP Bionews
Matthew Levy , Ph.D., assistant professor of biochemistry at Albert Einstein College of Medicine of Yeshiva University, has been awarded more than $700,000 by Stand Up To Cancer (SU2C) for his high-risk/high-reward cancer research . Dr. Levy's work will focus on creating self-guiding drugs that target only cancer cells , thus eliminating or significantly reducing serious or unpleasant side effects of current therapies. Dr. Levy is one of 13 ...
Related contentPST Names Energy Advocate Award Winners
9 hours ago ago from Idaho Samizdat: Nuke Notes
Media Contact: Lane Allgood (208) 313-4166 Idaho Falls, ID - December 8, 2009 The Partnership for Science and Technology (PST) is pleased to announce the winners of its 2009 Energy Advocate Awards. The awards are presented to individuals or organizations that were central to a noteworthy achievement in an energy or environmental field that is of interest to PST and its membership. Awards Banquet December 19th, Red Lion Inn, Idaho ...
Related contentEsophageal Cancer Treatment | Cancer Information
1 hour, 35 minutes ago ago from Cancer Information | Symptom, Prevention And Treatment
A new technique is showing promise in saving the lives of people with cancer of the esophagus. It's minimally invasive and the recovery time is quicker than ever. H. Lee Moffitt Cancer Center & Research Institute in Tampa, Florida is leading the way in the laparoscopic esophagectomy. This is one of the fastest rising cancers in the United States. 14000 Americans are diagnosed every year. Moffitt's Dr. Scott Kelley is one of the few surgeons ...
Related contentSpices Halt Growth of Breast Stem Cells That Fuel Cancer Growth | The X-Journals
14 hours ago ago from The X-Journals
Categories Anomalies, Suppressed Research & 21st Century Science Blake Harris: Documentary & Investigative Field Notes Books Frontiers of Scientific Exploration Future Trends & New Paradigms Human Ecology, Climate Change, Sustainability Suppressed Technology & Research Uncategorized Videos & Multimedia Pages Advertising Placement & Guidelines Contact Information Contributors General Approach of This Site Note on Copyrights Online Books ...
Related contentAmerican Association For Cancer Research Responds To Decline In Cancer Incidence And Death Rates
2 hours ago ago from Medical News Hour
Incidence and death rates for all cancers combined continue to steadily decline, according to data released today in the Annual Report to the Nation on the Status of Cancer, 1975-2006. On average, new diagnoses for all types of cancer combined decreased almost one percent per year from 1999 to 2006. From 2001 to 2006, cancer deaths decreased 1.6 percent Read the original: American Association For Cancer Research Responds To Decline ...
Related contentRelated News
Scientist at Work: A. Thomas McLellan: Addiction on 2 Fronts: Work and Home
19 hours ago ago from The New York Times
WASHINGTON His son had been dead from an overdose only three months when A. Thomas McLellan, among the nation's leading researchers on addiction, got a call from the office of Vice President Joseph R. Biden Jr. Would he accept the nomination to be the government's No. 2 drug-control official? Brendan Smialowski for The New York Times A PERSONAL MATTER A. Thomas McLellan says he is working against not just drug abuse, but also ...
Related contentOxford BioTherapeutics Appoints Michael Moore as Chairman
5 hours ago ago from FanHouse
OXFORD, England , December 9 /PRNewswire/ -- - Appointment Follows Recent Recruitment of Senior Antibody Industry Leaders and Highlights OBT's Growth Into a Leading Oncology-Focused Therapeutic Antibody Company Oxford BioTherapeutics (OBT) has today announced the appointment of Dr Michael Moore as non-executive Chairman. Dr Moore brings considerable expertise and experience to OBT at an exciting phase in the Company's development, as it ...
Related content
